6951 - 6975 of 8808 Results
Title
Year
-
OPENTitle: Depressive symptoms precede cognitive impairment in de novo Parkinson’s disease patients: Analysis of the PPMI cohort.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 33Issue #: 8Start Page: 1111End Page: 1120Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1037/neu0000583Best OA location URL: https://doi.org/10.1037/neu0000583Citation Count: 32
-
OPENTitle: Intraindividual variability in neuropsychological performance predicts longitudinal cortical volume loss in early Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 36Issue #: 6Start Page: 513End Page: 519Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1037/neu0000809Best OA location URL: https://doi.org/10.1037/neu0000809Citation Count: 5
-
OPENTitle: Physical inactivity links depressive symptoms and cognitive functioning among individuals with Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 36Issue #: 6Start Page: 505End Page: 512Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1037/neu0000837Best OA location URL: https://doi.org/10.1037/neu0000837Citation Count: 7
-
OPENTitle: Sex Differences in Cognitive Changes in De Novo Parkinson’s DiseaseJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 26Issue #: 2Start Page: 241End Page: 249Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617719001085Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7282562Citation Count: 12
-
OPENTitle: Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 16Issue #: 1Start Page: 66End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(16)30328-3Best OA location URL: http://doi.org/10.1016/S1474-4422(16)30328-3Citation Count: 380
-
OPENTitle: Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validationJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 16Issue #: 11Start Page: 908End Page: 916Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(17)30328-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5693218Citation Count: 147
-
OPENTitle: Increased striatal dopamine in carriers of GBA mutations: compensation or epiphenomenon?Journal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 27End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30355-2Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6924570Citation Count: 1
-
RESTRICTEDTitle: Developing therapies for Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 10Start Page: 797End Page: 797Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30320-3Best OA location URL: http://www.thelancet.com/article/S1474442220303203/pdfCitation Count: 5
-
OPENTitle: Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association dataJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 15Issue #: 6Start Page: 585End Page: 596Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/s1474-4422(16)00071-5Best OA location URL: http://www.thelancet.com/article/S1474442216000715/pdfCitation Count: 92
-
OPENTitle: Updated Parkinson's disease motor subtypes classification and correlation to cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid levelsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 8Issue #:Start Page: 100187End Page: 100187Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2023.100187Best OA location URL: https://doi.org/10.1016/j.prdoa.2023.100187Citation Count: 15
- Longitudinal hippocampal subfields, CSF biomarkers, and cognition in patients with Parkinson disease2023OPENTitle: Longitudinal hippocampal subfields, CSF biomarkers, and cognition in patients with Parkinson diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 9Issue #:Start Page: 100199End Page: 100199Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2023.100199Best OA location URL: https://doi.org/10.1016/j.prdoa.2023.100199Citation Count: 2
-
OPENTitle: NRM 2021 Abstract BookletJournal Name: Journal of Cerebral Blood Flow & MetabolismPublisher: SAGE PublicationsVol: 41Issue #: 1_supplStart Page: 11End Page: 309Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/0271678x211061050Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/0271678X211061050Citation Count: 1
-
OPENTitle: The 3-Item “Apathy” Subscale Within the GDS-15 Is Not Supported in De Novo Parkinson’s Disease Patients: Analysis of the PPMI CohortJournal Name: Journal of Geriatric Psychiatry and NeurologyPublisher: SAGE PublicationsVol: 35Issue #: 3Start Page: 309End Page: 316Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/0891988720988908Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9637029Citation Count: 5
-
OPENTitle: A Survey of People With Parkinson’s and Their Carers: The Management of Pain in Parkinson’sJournal Name: Journal of Geriatric Psychiatry and NeurologyPublisher: SAGE PublicationsVol: 35Issue #: 4Start Page: 613End Page: 621Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/08919887211023592Best OA location URL: https://doi.org/10.1177/08919887211023592Citation Count: 12
-
OPENTitle: Early Autonomic Symptoms Predict Functional Decline in Parkinson’s Disease Independent of Dopaminergic TherapyJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 22Issue #: 1Start Page: 15End Page: 23Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000525664Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9671814Citation Count: 3
-
OPENTitle: Morphological Characterization of Functional Brain Imaging by Isosurface Analysis in Parkinson’s DiseaseJournal Name: International Journal of Neural SystemsPublisher: World Scientific Pub Co Pte LtVol: 30Issue #: 09Start Page: 2050044End Page: 2050044Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1142/s0129065720500446Best OA location URL: https://hdl.handle.net/10630/28113Citation Count: 29
- Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease2015OPENTitle: Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 87Issue #: 8Start Page: 864End Page: 870Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2015-311827Best OA location URL: http://doi.org/10.1136/jnnp-2015-311827Citation Count: 121
-
OPENTitle: Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohortJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 89Issue #: 1Start Page: 78End Page: 88Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2017-316213Best OA location URL: https://escholarship.org/uc/item/3jc4p43xCitation Count: 107
-
OPENTitle: Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohortsJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 93Issue #: 9Start Page: 952End Page: 959Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2021-327376Best OA location URL: https://jnnp.bmj.com/content/jnnp/93/9/952.full.pdfCitation Count: 11
-
OPENTitle: Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' studyJournal Name: BMJ OpenPublisher: BMJVol: 10Issue #: 8Start Page: e038911End Page: e038911Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1136/bmjopen-2020-038911Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/10/8/e038911.full.pdfCitation Count: 28
- Ca 2+ channels couple spiking to mitochondrial metabolism in substantia nigra dopaminergic neurons2022OPENTitle: Ca 2+ channels couple spiking to mitochondrial metabolism in substantia nigra dopaminergic neuronsJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 39Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.abp8701Best OA location URL: https://doi.org/10.1126/sciadv.abp8701Citation Count: 54
-
OPENTitle: Reduced thalamic excitation to motor cortical pyramidal tract neurons in parkinsonismJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 34Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adg3038Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.adg3038?download=trueCitation Count: 11
-
OPENTitle: Artificial intelligence–coupled plasmonic infrared sensor for detection of structural protein biomarkers in neurodegenerative diseasesJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 28Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.adg9644Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.adg9644?download=trueCitation Count: 60
-
OPENTitle: APOE genotype regulates pathology and disease progression in synucleinopathyJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 12Issue #: 529Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aay3069Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7289511Citation Count: 149
-
OPENTitle: Neuronal hyperactivity–induced oxidant stress promotes in vivo α-synuclein brain spreadingJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 35Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.abn0356Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.abn0356?download=trueCitation Count: 25